WebMar 13, 2024 · Eagle Pharmaceuticals (EGRX) Beats Q4 Earnings and Revenue Estimates Zacks Mar. 13, 2024, 08:05 AM Eagle Pharmaceuticals (EGRX) came out with quarterly earnings of $1.10 per share,... WebMar 13, 2024 · Eagle Pharmaceuticals (EGRX) Beats Q4 Earnings and Revenue Estimates Zacks Mar. 13, 2024, 08:05 AM Eagle Pharmaceuticals (EGRX) came out …
Eagle Pharmaceuticals Non-GAAP EPS of $1.11 beats by $0.28, …
WebApr 14, 2024 · The company has a market cap of $5.22 billion, a P/E ratio of 12.51 and a beta of 1.31. Eagle Materials ( NYSE:EXP - Get Rating) last posted its quarterly earnings results on Thursday, January 26th. The construction company reported $3.20 earnings per share for the quarter, topping the consensus estimate of $3.19 by $0.01. WebMar 13, 2024 · Full-year 2024 revenue was $316.6 million, compared to $171.5 million in 2024. Net product sales during the fourth quarter of 2024 were $37.2 million, compared to $16.2 million in Q4 of 2024. Full ... how to sift rocks out of dirt
Eagle Pharmaceuticals, Inc. (EGRX) - Yahoo Finance
WebNov 9, 2024 · Following the latest upgrade, the three analysts covering Eagle Pharmaceuticals provided consensus estimates of US$273m revenue in 2024, which would reflect an uneasy 8.5% decline on its sales ... WebMar 13, 2024 · The specialty pharmaceutical company posted revenue of $60.7 million in the period. For the year, the company reported net income of $35.6 million, or $2.73 per share, swinging to a profit in the period. Revenue was reported as $316.6 million. Eagle Pharmaceuticals expects full-year earnings in the range of $4.20 to $4.53 per share. … WebAug 10, 2024 · Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced financial results for the three and six months ended June 30, 20 ... Revenue: Product sales $ 14,376 ... how to sight a 243